Sindrom Rett

01Pathophysiology

Rett syndrome is a neurodevelopmental disorder caused by mutations in the MECP2 gene, which encodes methyl-CpG binding protein 2. This protein functions as a transcriptional regulator that is essential for neuronal maturation, dendritic arborization, and synaptic plasticity. When MECP2 is absent or dysfunctional, neurons develop initially but fail to maintain their synaptic connections and mature circuitry. This explains the hallmark regression pattern: the child appears normal in the first months of life because residual maternal MECP2 protein and early neuronal processes do not yet depend heavily on MECP2 function.

The reason onset occurs at 7 to 24 months (as stated in PPDGJ-III) is that this is the developmental window when higher cortical functions (purposeful hand use, expressive language, social reciprocity) begin to demand robust synaptic maintenance. The failure of MECP2 at this stage produces the characteristic loss of acquired hand skills and language, which the PPDGJ-III identifies as the most prominent clinical feature.

The stereotypic hand-wringing is thought to arise because the motor cortex loses its ability to generate voluntary, goal-directed hand movements, and the released subcortical circuits produce repetitive, involuntary patterns. This same cortical-subcortical imbalance underlies the ataxia, broad-based gait, and eventual spasticity described in the diagnostic guidelines.

Autonomic dysregulation is a key consequence of brainstem involvement. The PPDGJ-III notes frequent hyperventilation episodes, which reflect dysfunction of respiratory patterning centers. Similarly, the near-universal failure of bowel and bladder control points to autonomic pathways being affected early and persistently.

The condition is X-linked dominant, which is why it overwhelmingly affects females. Males carrying a single mutant MECP2 copy on their sole X chromosome typically die in utero or in the neonatal period from severe encephalopathy. Females survive because of random X-inactivation: in each cell, one X is silenced, so a mosaic of normal and MECP2-deficient neurons exists, producing a variable but survivable phenotype.

02Clinical Manifestation and Staging

The PPDGJ-III highlights that unlike autism, self-injurious behavior and complex or routine-based stereotypies are rare in Rett syndrome. This is a deliberate discriminator placed in the diagnostic guidelines and is a frequently tested distinction.

The retained social smile is a classic finding. The PPDGJ-III describes it as the ability to "smile socially" and gaze at someone with a "blank" quality, but without true social interaction in the early childhood period. This paradox (smiling without interacting) is a vignette hallmark.

03Diagnostic Workup

Rett syndrome is fundamentally a clinical diagnosis. The PPDGJ-III criteria function as both the best initial test and the diagnostic framework: a female child with (1) normal or near-normal early development, (2) onset of regression at 7 to 24 months, (3) loss of acquired purposeful hand movements replaced by stereotypic hand-wringing, (4) loss or impairment of language, and (5) deceleration of head growth meets the clinical profile.

The most accurate confirmatory test is MECP2 mutation analysis via molecular genetic testing. This is ordered when the clinical picture is consistent and you want definitive confirmation. About 95% of patients with classic Rett syndrome will have an identifiable MECP2 mutation. A negative MECP2 result does not completely exclude the diagnosis if the clinical criteria are fully met, because rare cases can involve mutations in CDKL5 or FOXG1 (atypical Rett variants).

EEG is not used to diagnose Rett syndrome per se, but it is essential for characterizing seizures. The PPDGJ-III notes that epileptic seizures occur in most cases with onset before age 8, typically presenting as brief, small seizures. EEG will show progressive background slowing and epileptiform activity, which helps guide antiepileptic drug selection.

Brain MRI is ordered primarily to rule out alternative structural diagnoses (tumors, metabolic leukodystrophies, congenital malformations). In Rett syndrome, MRI may show mild, non-progressive cerebral atrophy, but it is not diagnostic on its own.

Head circumference monitoring is a simple but highly testable screening measure. A girl whose head circumference was tracking along a normal percentile and then falls away is a classic vignette setup. This acquired microcephaly (not congenital) is a distinguishing feature.

04Management and Treatment

There is no curative treatment for Rett syndrome. Management is entirely symptomatic and supportive, with the goal of maximizing quality of life and functional capacity.

Seizure management is one of the most testable treatment topics. Valproic acid has traditionally been a first-line agent, particularly for generalized seizure types. Lamotrigine is an alternative, especially when valproate side effects (weight gain, hepatotoxicity, teratogenicity in reproductive-age patients) are a concern. Levetiracetam is increasingly used as a well-tolerated option. Carbamazepine can be considered for focal seizures. The "next best step" when seizures are refractory to monotherapy is to confirm compliance, reassess the seizure type with repeat EEG, and consider combination therapy rather than immediately escalating to surgical evaluation.

Physical and occupational therapy should begin early and continue throughout life. The PPDGJ-III describes the progression from broad-based gait and hypotonia to eventual spasticity and loss of ambulation. Therapy aims to delay these transitions by maintaining joint range of motion, building core strength, and providing adaptive walking aids. Once the patient is no longer ambulatory, therapy shifts to wheelchair positioning and prevention of pressure injuries.

Nutritional support is often underestimated. The PPDGJ-III notes chewing difficulty, and many patients are underweight due to increased caloric expenditure from stereotypic movements and poor oral intake. When oral feeding becomes unsafe or insufficient, a percutaneous endoscopic gastrostomy (PEG) tube is considered.

Scoliosis surveillance must be systematic. Clinical and radiographic assessment should occur at least annually once the child reaches school age, as progressive scoliosis is described in the PPDGJ-III as a common feature. Curves exceeding 40 to 50 degrees with documented progression are typically referred for surgical correction (posterior spinal fusion).

Autonomic symptoms including hyperventilation, breath-holding, and cardiac rhythm disturbances require ongoing monitoring. Prolonged QTc interval has been reported, and an ECG should be obtained at baseline and periodically, especially before prescribing medications that can prolong QT.

05Differential Diagnosis and Distractors

06Traps and High-Yield Pearls

The most common way students get Rett syndrome questions wrong is by confusing it with autism. Both conditions appear in the pervasive developmental disorder category within the PPDGJ-III, and both involve social withdrawal and stereotypic behavior, which makes them easy to conflate at first glance. The critical discriminator is the regression pattern: a previously normal girl who loses hand skills and speech and develops hand-wringing is Rett, not autism. The PPDGJ-III itself provides the clue by explicitly noting that self-injurious behavior and complex ritualistic stereotypies (classic autism features) are "rarely seen" in Rett.

Another common trap involves sex. Rett syndrome is tested almost exclusively in female patients. If a vignette describes a boy with the same findings, the answer is almost certainly not Rett. The rare male cases exist but are severe neonatal encephalopathy, not the classic staged regression pattern. A female child in the vignette is a deliberate signpost.

Students also stumble on the "social smile" paradox. The PPDGJ-III notes that children with Rett syndrome retain their social smile and can gaze at people, which tempts students into thinking the child has intact social function. But the guideline also states there is no true social interaction in early childhood. The test is checking whether you understand that a social smile alone does not equal normal social development.

Finally, watch for the head circumference clue. A vignette that mentions a declining head circumference percentile after normal early growth is pointing you directly at Rett syndrome. Acquired microcephaly (deceleration of head growth, not congenitally small head) is one of the most reliable distinguishing features and is among the first criteria listed in the PPDGJ-III guidelines. If you see it, lock in on Rett and verify with the rest of the clinical picture.

The core competency being tested with Rett syndrome questions is the ability to recognize a staged regression pattern in a female infant, distinguish it from autism and other regressive disorders, and identify the pathognomonic triad of lost hand skills, hand-wringing stereotypies, and acquired microcephaly.